APA (7th ed.) Citation

Aslankoc, R., Ozmen, O., Karabacak, P., Aslan, C., Kavrik, O., & Sancer, O. (2025). Fluvoxamine Attenuates Liver Injury in Lipopolysaccharide‐Induced Sepsis: Via Nrf2/HO‐1 Pathway. Fundamental & Clinical Pharmacology, 39(4), 1. https://doi.org/10.1111/fcp.70031

Chicago Style (17th ed.) Citation

Aslankoc, Rahime, Ozlem Ozmen, Pınar Karabacak, Cahide Aslan, Oguzhan Kavrik, and Okan Sancer. "Fluvoxamine Attenuates Liver Injury in Lipopolysaccharide‐Induced Sepsis: Via Nrf2/HO‐1 Pathway." Fundamental & Clinical Pharmacology 39, no. 4 (2025): 1. https://doi.org/10.1111/fcp.70031.

MLA (9th ed.) Citation

Aslankoc, Rahime, et al. "Fluvoxamine Attenuates Liver Injury in Lipopolysaccharide‐Induced Sepsis: Via Nrf2/HO‐1 Pathway." Fundamental & Clinical Pharmacology, vol. 39, no. 4, 2025, p. 1, https://doi.org/10.1111/fcp.70031.